Methylene chloride induced mouse liver and lung tumours: An overview of the role of mechanistic studies in human safety assessment

Human and Experimental Toxicology

Volumn 16, Issue 1, 1997, Pages 3-13

  Green, Trevor ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Cancer; Human safety assessment; Methylene chloride

Indexed keywords

DICHLOROMETHANE; DNA; GLUTATHIONE TRANSFERASE;

ANIMAL MODEL; ARTICLE; CELL DIVISION; CLARA CELL; DNA DAMAGE; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME LOCALIZATION; GENOTOXICITY; HAMSTER; HUMAN; LIVER CARCINOGENESIS; LIVER TUMOR; LUNG CARCINOGENESIS; LUNG TUMOR; METABOLISM; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALIA; CRICETINAE;

EID: 0031015191     PISSN: 01445952     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327197016001021     Document Type: Article

References (60)

1. NTP. National Toxicology Program technical report on the toxicology and carcinogenesis studies of dichloromethane in F344/N rats and B6C3F1 mice. NTP TR 306, Final Report. 1986-Jan.
2. Burek JD et al. Methylene chloride; A two year inhalation toxicity and oncogenicity study in rats and hamsters. Fundemental and Applied Toxicology 1984; 4: 30-47.
3. Serota DG et al. A two year drinking-water study of dichloromethane in rodents, II. Mice. Food and Chemical Toxicology 1986; 24: 959-63.
4. Serota DG et al. A two year drinking-water study of dichloromethane in rodents, I. Rats. Food and Chemical Toxicology 1986; 24: 951-8.
5. Nitschke KD et al. A 2 year inhalation toxicity and oncogenicity study in rats. Fundemental and Applied Toxicology 1988; 11: 48-59.
6. * - Industry sponsored studies ECETOC. The assessment of carcinogenic hazard for human beings exposed to methylene chloride. Technical Report No. 26. ECETOC, Brussels, 1987.
7. EPA. Addendum to the health assessment document for dichloromethane (methylene chloride). United States Environmental Protection Agency EPA-600/8-82-004FF. Final Report, 1985.
8. * - Industry sponsored studies Green T. The metabolic activation of dichloromethane and chlorofluoromethane in a bacterial mutation assay using Salmonella typhimurium. Mutation Research 1983; 118: 277-88.
9. Jongen WMF et al. Mutagenicity testing of dichloromethane in short-term mammalian tests. Mutation Research 1981; 81: 203-13.
10. Thilager AK, Kumaroo V. Induction of chromosome damage by methylene chloride in CHO cells. Mutation Research 1983; 116: 361-7.
11. Thilager AK et al. Evaluation of dichloromethane in short-term in vitro genetic toxicity assays. Environmental Mutagenesis 1984; 6: 418-9.
12. * - Industry sponsored studies Sheldon T, Richardson CR, Elliott BM. Inactivity of methylene chloride in the mouse bone marrow micronucleus assay. Mutagenesis 1987; 2: 57-9.
13. * - Industry sponsored studies Trueman RW, Ashby J. Lack of UDS activity in the livers of mice exposed to dichloromethane. Environmental and Molecular Mutagenesis 1987; 10: 189-95.
14. Raje R, Basso M, Tolen T, Greening M. Evaluation of in vivo mutagenicity of low dose methylene chloride in mice. Journal of the American College of Toxicology 1988; 7: 699-703.
15. * - Industry sponsored studies Lefevre PA, Ashby J. Evaluation of dichloromethane as an inducer of DNA synthesis in the B6C3F1 mouse liver. Carcinogenesis 1989; 10: 1067-72.
16. * - Industry sponsored studies Green T, Provan WM, Collinge DC, Guest AE. Macromolecular interactions of inhaled methylene chloride in rats and mice. Toxicology and Applied Pharmacology 1988; 93: 1-10.
17. Westbrook-Collins B, Allen JW, Sharief Y, Campbell J. Further evidence that dichloromethane does not induce chromosome damage. Journal of Applied Toxicology 1990; 10: 79-81.
18. Allen et al. Cytogenetic analysis of mice exposed to dichloromethane. Environmental and Molecular Mutagenesis 1990; 15: 1-228.
19. Foley JF et al. Inhalation exposure to a hepatocarcinogenic concentration of methylene chloride does not induce sustained replicative DNA synthesis in hepatocytes of female B6C3F1 mice. Carcinogenesis 1993; 14: 811-7.
20. * - Industry sponsored studies Foster JR, Hext PM, Green T. The bronchiolar Clara cell: selective cytotoxicity with methylene chloride. Electron Microscopy Proc. 11th. Int. Congr., 1986; 2755-66.
21. * - Industry sponsored studies Foster JR et al. Methylene chloride - An inhalation study to investigate pathological and biochemical events occurring in the lungs of mice over an exposure period of 90 days. Fundemental and Applied Toxicology 1992; 18: 376-88.
22. * - Industry sponsored studies Foster JR, Green T, Smith LL, Tittensor S, Wyatt I. Methylene chloride: an inhalation study to investigate toxicity in the mouse lung using morphological, biochemical and Clara cell culture techniques. Toxicology 1994; 91: 221-34.
23. Heck Hd'A, Connolly R, Casanova M. DNA-protein crosslinks and cell proliferation in mice exposed to dichloromethane: Risk assessment with DPX as dosimeter. The Toxicologist 1996; 30: 473.
24. Devereux TR, Foley JR, Maronpot RR, Kari F, Anderson M. Ras proto-oncogene activation in liver and lung tumours from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis 1993; 14: 795-801.
25. Kubic VL, Anders MW. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies on the mechanism of the reaction. Drug Metabolism and Disposition 1975; 3: 104-12.
26. Kubic VL, Anders MW. Metabolism of dihalomethanes to carbon monoxide. III. Studies on the mechanism of the reaction. Biochemical Pharmacology 1978; 27: 2349-55.
27. Ahmed AE, Anders MW. Metabolism of dihalomethanes to formaldehyde and inorganic chloride. Drug Metabolism and Disposition 1976; 4: 357-61.
28. Ahmed AE, Anders MW. Metabolism of dihalomethanes to formaldehyde and inorganic halide. II. Studies on the mechanism of the reaction. Biochemical Pharmacology 1978; 27: 2021-25.
29. Gargas ML, Clewell HJ, Anderson ME. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. Toxicology and Applied Pharmacology 1986; 82: 211-23.
30. Guengerich FP, Kim DH, Iwasai M. Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology 1991; 4: 168-79.
31. Meyer DJ et al. Theta, a new class of glutathione transferases purified from rat and man. Biochemical Journal 1991; 274: 409-14.
32. * - Industry sponsored studies Mainwaring GW, Davidson M, Green T. The isolation of a theta class glutathione S-transferases active with methylene chloride. Biochemical Journal 1996a; 314: 445-8.
33. * - Industry sponsored studies Green T. A biological data base for methylene chloride risk assessment. In Travis, C.C. (ed.). Biologically-Based Methods for Cancer Risk Assessment. Plenum, New York, pp. 289-300, 1989.
34. Reitz RH, Mendrala AL, Guengerich FP. In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models. Toxicology and Applied Pharmacology 1989; 97: 230-46.
35. Bogaards JPP, van Ommen B, van Bladeren PJ. Interindividual differences in the in vitro conjugation of methylene chloride with glutathione S-transferase in 22 human samples. Biochemical Pharmacology 1993; 45: 2166-69.
36. * - Industry sponsored studies Graves RJ, Coutts C, Green T. Methylene chloride induced DNA damage: An interspecies comparison. Carcinogenesis 1995; 16: 1919-26.
37. Hallier E et al. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Archives of Toxicology 1993; 67: 173-8.
38. Hallier E et al. Metabolism of dichloromethane (methylene chloride) to formaldehyde in human erythrocytes: influence of polymorphism of glutathione transferase Theta (GST T1-1). Archives of Toxicology 1994; 69: 423-7.
39. Pemble et al. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical Journal 1994; 300: 274-76.
40. Schroder KR et al. Purification and characterisation of a new glutathione S-transferase, class theta, from human erythrocytes. Archives of Toxicology 1996; 70: 559-66.
41. EPA. Update to the Health Assessment Document and Addendum for Dichloromethane (Methylene Chloride): Pharmacokinetics, Mechanism of Action, and Epidemiology. United States Environmental Protection Agency External Review Draft. NTIS/PB87-228565, 1987.
42. Andersen ME et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicology and Applied Pharmacology 1987; 87: 185-205.
43. * - Industry sponsored studies ECETOC. Methylene chloride (dichloromethane): Human risk assessment using experimental animal data. Technical Report No. 32. ECETOC Brussels, 1988.
44. Kari FW et al. Effect of varying exposure regimens on methylene chloride-induced lung and liver tumours in female B6C3F1 mice. Carcinogenesis 1993; 14: 819-26.
45. Maronpot RR et al. Hepatic and pulmonary carcinogenicity of methylene chloride in mice: a search for mechanisms. Toxicologist 1995; 102: 73-81.
46. La Roche SD, Leisinger T. Sequence analysis and expression of the bacterial dichloromethane dehalogenase structural gene, a member of the glutathione S-transferase supergene family. Journal of Bacteriology 1990; 172: 164-71.
47. Thier R et al. Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base pair mutations upon exposure to dihalomethanes. Proceedings of the National Academy of Science 1993; 90: 8576-80.
48. * - Industry sponsored studies Graves RJ, Callander RD, Green T. The role of formaldehyde and S-chloromethylglutathione in the bacterial mutagenicity of methylene chloride. Mutation Research 1994; 320: 235-43.
49. Dechert S, Dekant W. The possible role of S-chloromethylglutathione in the genotoxicity of dichloromethane. The Toxicologist 1996; 30: 479.
50. * - Industry sponsored studies Graves RJ, Coutts C, Eyton-Jones H, Green T. Relationship between hepatic DNA damage and methylene chloride-induced hepatocarcinogenicity in B6C3F1 mice. Carcinogenesis 1994; 15: 991-6.
51. * - Industry sponsored studies Graves RJ, Trueman P, Jones S, Green T. DNA sequence analysis of methylene chloride induced HPRT mutations in CHO cells: Comparison with the mutation spectrum obtained for 1,2-dibromoethane and formaldehyde. Mutagenesis 1996; 11: 229-33.
52. * - Industry sponsored studies Graves RJ, Green T. Mouse liver glutathione S-transferase mediated metabolism of methylene chloride to a mutagen in the CHO/HPRT assay. Mutation Research 1996; 367: 143-50.
53. Casanova M, Deyo DF, Heck H. Dichloromethane (methylene chloride): Metabolism to formaldehyde and formation of DNA-protein crosslinks in B6C3F1 mice and Syrian golden hamsters. Toxicology and Applied Pharmacology 1992; 114: 162-5.
54. * - Industry sponsored studies Mainwaring GW, Foster JR, Green T. The distribution of theta class glutathione-S-transferases in mouse, rat and human liver and lung. Biochemical Journal 1996b; 318: 297-303.
55. Hearne FT, Pifer JW, Grose F. Absence of adverse mortality effects in workers exposed to methylene chloride: an update. Journal of Occupational Medicine 1990; 32; 234-40.
56. Gibbs GW. The mortality of workers employed at a cellulose acetate and triacetate fibers plant in Cumberland Marylane, a 1970 cohort followed 1970-1989. Final rep. by Safety Health Environmental International Consultants, Winterburn, Alberta. Somerville, NJ. Hoechst Celanese, 1992.
57. Tommenson JA, Bonner SM, Heijne CG, Farrar DG. Mortality of workers employed at a plant producing cellulose triacetate film base. The Toxicologist 1996; 30: 481.
58. Lanes SF, Rothman KJ, Dreyer NA, Soden KJ. Mortality update of cellulose fiber production workers. Scandinavian Journal of Work and Environmental Health 1993; 19: 426-8.
59. Heineman EF et al. Occupational exposure to chlorinated aliphatic hydrocarbons and risk of astrocytic brain cancer. American Journal of Industrial Medicine 1994; 26: 155-69.
60. EPA. Proposed guidelines for carcinogen risk assessment. United States Environmental Protection Agency. Federal Register 1996; 61: 17960.